CN115216288B - High-sensitivity double-flux detection immunochromatography test strip based on double-excitation orthogonal emission up-conversion luminescence nano-particles - Google Patents
High-sensitivity double-flux detection immunochromatography test strip based on double-excitation orthogonal emission up-conversion luminescence nano-particles Download PDFInfo
- Publication number
- CN115216288B CN115216288B CN202210582109.5A CN202210582109A CN115216288B CN 115216288 B CN115216288 B CN 115216288B CN 202210582109 A CN202210582109 A CN 202210582109A CN 115216288 B CN115216288 B CN 115216288B
- Authority
- CN
- China
- Prior art keywords
- detection
- excitation
- double
- test strip
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 134
- 238000001514 detection method Methods 0.000 title claims abstract description 117
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 82
- 238000012360 testing method Methods 0.000 title claims abstract description 59
- 238000004020 luminiscence type Methods 0.000 title claims abstract description 32
- 238000003317 immunochromatography Methods 0.000 title claims abstract description 22
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 55
- 239000010931 gold Substances 0.000 claims abstract description 47
- 229910052737 gold Inorganic materials 0.000 claims abstract description 45
- 239000012528 membrane Substances 0.000 claims abstract description 38
- 230000005284 excitation Effects 0.000 claims abstract description 35
- 239000000427 antigen Substances 0.000 claims abstract description 29
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 29
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 28
- 108091007433 antigens Proteins 0.000 claims abstract description 26
- 102000036639 antigens Human genes 0.000 claims abstract description 26
- RWQKHEORZBHNRI-BMIGLBTASA-N ochratoxin A Chemical compound C([C@H](NC(=O)C1=CC(Cl)=C2C[C@H](OC(=O)C2=C1O)C)C(O)=O)C1=CC=CC=C1 RWQKHEORZBHNRI-BMIGLBTASA-N 0.000 claims abstract description 13
- LINOMUASTDIRTM-QGRHZQQGSA-N deoxynivalenol Chemical compound C([C@@]12[C@@]3(C[C@@H](O)[C@H]1O[C@@H]1C=C(C([C@@H](O)[C@@]13CO)=O)C)C)O2 LINOMUASTDIRTM-QGRHZQQGSA-N 0.000 claims abstract description 11
- LINOMUASTDIRTM-UHFFFAOYSA-N vomitoxin hydrate Natural products OCC12C(O)C(=O)C(C)=CC1OC1C(O)CC2(C)C11CO1 LINOMUASTDIRTM-UHFFFAOYSA-N 0.000 claims abstract description 11
- VYLQGYLYRQKMFU-UHFFFAOYSA-N Ochratoxin A Natural products CC1Cc2c(Cl)cc(CNC(Cc3ccccc3)C(=O)O)cc2C(=O)O1 VYLQGYLYRQKMFU-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 10
- DAEYIVCTQUFNTM-UHFFFAOYSA-N ochratoxin B Natural products OC1=C2C(=O)OC(C)CC2=CC=C1C(=O)NC(C(O)=O)CC1=CC=CC=C1 DAEYIVCTQUFNTM-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000126 substance Substances 0.000 claims abstract description 10
- 230000002745 absorbent Effects 0.000 claims abstract description 4
- 239000002250 absorbent Substances 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims description 18
- 229910052769 Ytterbium Inorganic materials 0.000 claims description 9
- 101100449517 Arabidopsis thaliana GRH1 gene Proteins 0.000 claims description 7
- 101100434479 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) AFB1 gene Proteins 0.000 claims description 7
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 claims description 7
- 229930020125 aflatoxin-B1 Natural products 0.000 claims description 7
- 238000010791 quenching Methods 0.000 claims description 7
- 239000011258 core-shell material Substances 0.000 claims description 6
- 238000003908 quality control method Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 229910052779 Neodymium Inorganic materials 0.000 claims description 5
- 238000003760 magnetic stirring Methods 0.000 claims description 5
- 229910052691 Erbium Inorganic materials 0.000 claims description 4
- 230000002457 bidirectional effect Effects 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000003365 glass fiber Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 230000000171 quenching effect Effects 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 3
- 230000007423 decrease Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 229910001112 rose gold Inorganic materials 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 3
- 239000012498 ultrapure water Substances 0.000 claims description 3
- 238000002372 labelling Methods 0.000 claims description 2
- 230000002146 bilateral effect Effects 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 239000000243 solution Substances 0.000 description 22
- 239000011259 mixed solution Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 7
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 7
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 7
- 239000005642 Oleic acid Substances 0.000 description 7
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 7
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 7
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 7
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadecene Natural products CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- 231100000678 Mycotoxin Toxicity 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000002636 mycotoxin Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 2
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 238000001132 ultrasonic dispersion Methods 0.000 description 2
- KWILGNNWGSNMPA-LURJTMIESA-N (R)-(-)-Mellein Natural products C1=CC(O)=C2C(=O)O[C@@H](C)CC2=C1 KWILGNNWGSNMPA-LURJTMIESA-N 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010043275 Teratogenicity Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000005210 lymphoid organ Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- KWILGNNWGSNMPA-UHFFFAOYSA-N mellein Chemical compound C1=CC(O)=C2C(=O)OC(C)CC2=C1 KWILGNNWGSNMPA-UHFFFAOYSA-N 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 231100000211 teratogenicity Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/58—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing copper, silver or gold
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/77—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals
- C09K11/7766—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals containing two or more rare earth metals
- C09K11/7772—Halogenides
- C09K11/7773—Halogenides with alkali or alkaline earth metal
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
- G01N2333/38—Assays involving biological materials from specific organisms or of a specific nature from fungi from Aspergillus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
- G01N2333/385—Assays involving biological materials from specific organisms or of a specific nature from fungi from Penicillium
Abstract
The invention provides a high-sensitivity double-flux detection immunochromatography test strip based on double-excitation orthogonal emission up-conversion luminescent nano particles. The up-conversion luminescence nano-particles can emit red light or green light at any one wave band under the excitation of two different near infrared lights at the same time, namely, one near infrared excitation light can excite light of one wave band. The sample pad of the double-flux immunochromatographic test strip is arranged in the center of the bottom plate, and the two sides of the sample pad are symmetrically and sequentially adhered with the binding pad, the nitrocellulose membrane and the absorbent paper. Unlike one-way test paper, the double-pass test paper has gold grains coupled with ochratoxin A and vomitoxin antibody fixed separately to the two end combining pads and up-converting nanometer luminous grains coupled with ochratoxin A and vomitoxin antigen fixed onto corresponding T line. The invention can realize high-sensitivity and rapid detection of two detection substances. The method has the advantages of simple operation, low cost, low detection background value, stable signal and higher sensitivity.
Description
Technical Field
The invention belongs to the technical field of biomedical diagnosis, and particularly relates to a high-sensitivity double-flux detection immunochromatography test strip based on double-excitation orthogonal emission up-conversion luminescence nano particles.
Background
Food safety is becoming a global issue with the growth of intensive agriculture and the food industry; the health reliability of food reaching the consumer's hand should be determined in a quick, economical, accurate manner, especially in terms of contaminant screening. In order to meet the requirements of rapid and on-site analysis, the development of biosensors for food quality control is receiving increasing attention.
Ochratoxin A and vomitoxin have become the main factors contaminating cereal and byproducts in China, and have synergistic effects with various toxins. They are widely found in nature, wherein wheat and corn are the most main contaminated crops, and even if the wheat and corn are ingested by people and livestock, the wheat and corn have strong nephrotoxicity, mutagenicity, teratogenicity and carcinogenicity, and the toxins reduce the immunity proliferation of lymphoid organs, reduce the whole immunity function, influence the humoral immunity response and generate negative feedback effect on cellular immunity, and the targeted detoxification method has proved to be unable to remove the pollution and harm of the two toxins effectively due to the high stability of the two toxins, so the basic research force must be increased to develop a more effective detection method to eliminate the damage of the mycotoxins from the source.
The immunoassay method plays a crucial role in the current rapid mycotoxin screening due to the simplicity, easiness and high specificity. Compared with an ELISA method, the immunoassay method based on the colloidal gold nanoparticles (AuNP) is simple and quick in sample preparation method, can obtain a result within 3-10 min, does not need complicated sample pretreatment, trained personnel and expensive and precise instruments, and is more suitable for on-site quick detection.
Upconverting nanoparticles are inorganic nanocrystals that convert near infrared light into shorter wavelength emissions. This unique photophysical property, coupled with the narrow emission bandwidth and large anti-stokes shift, makes UCNP an excellent optical label for biosensing, as they can be detected without optical background interference of the sample matrix, receiving increasing attention in improving detection performance.
Therefore, UCNPs are combined with traditional colloidal gold immunochromatography, a double-throughput immunochromatography test strip based on a UCNP-Au composite system is developed through the arrangement of a bidirectional T line, the simultaneous detection of ochracin A and vomitoxin is realized, the cost can be greatly saved, and the convenience and the sensitivity are improved.
Disclosure of Invention
In order to overcome the defects in the prior art, the invention provides a high-sensitivity double-flux detection immunochromatography test strip based on double-excitation orthogonal emission up-conversion luminescent nano particles. The up-conversion luminescence nano particles can emit red light or green light at any one wave band under the excitation of two different near infrared lights, namely, one near infrared excitation light can excite light of one wave band, the light can be combined with colloidal gold, and a brand-new double-flux detection mode is created by utilizing the bidirectional diffusion characteristic of liquid drops so as to realize multiple substance detection in food. The invention can realize single-line detection of various detection substances, and has simple and convenient operation, low cost and higher sensitivity.
In order to achieve the aim of the invention, the invention adopts the following technical scheme:
the preparation method of the dual-excitation orthogonal emission up-conversion luminescent nanoparticle is characterized by comprising the following steps of:
(1) Preparing a double-excitation orthogonal emission up-conversion luminescent nanoparticle with a three-layer core-shell structure by adopting a seed crystal method, wherein NaYF 4 nanoparticle doped with Yb, tm and Er is taken as an inner core, a first shell layer of Yb-doped NaYF 4 is wrapped outside the inner core, and a second shell layer of Yb-doped NaYF 4 and Nd-doped NaYF 4:Yb/Tm/Er@NaYF4:Yb@NaYF4 which is co-doped with Yb, tm, er and Nd is wrapped outside the first shell layer, so that a Yb/Nd core-shell structure is formed; the water-soluble dual-excitation orthogonal emission up-conversion luminescent nano-particles UCNPs are prepared, and the up-conversion luminescent nano-particles emit red light under the excitation of 980nm near infrared light and emit green light under the excitation of 808nm near infrared light.
The preparation method of the dual-excitation orthogonal emission up-conversion luminescent nanoparticle UCNPs is characterized by further comprising the following steps:
(2) Preparation of UCNPs-antigen: the antigen of the detection object is marked on the surface of the water-soluble dual-excitation orthogonal emission up-conversion luminescent nanoparticle through physical adsorption and the like, and the dual-excitation orthogonal emission up-conversion luminescent nanoparticle marked with the antigen of the detection object is obtained.
The preparation method of the gold nanoparticle is characterized by comprising the following steps of:
(1) Preparing a colloidal gold solution:
0.25mL of 0.1M chloroauric acid solution was added to 100mL of ultrapure water, and heated under magnetic stirring to reflux to boiling. 1.5mL of 1% sodium citrate solution was added rapidly and reflux continued for about 30 minutes. During which the color of the solution changed from pale yellow to black and then to deep red. And (3) cooling to room temperature, and filtering the prepared wine-red gold nanoparticle sol by using a filter membrane with the diameter of 0.22 mu m to obtain gold nanoparticles.
The preparation method of the gold nanoparticle AuNPs is characterized by further comprising the following steps:
(2) Preparation of AuNPs-antibodies: the gold nanoparticle labeled with the antibody of the object to be detected is obtained by labeling the antibody of the object to be detected on the surface of the gold nanoparticle through physical adsorption and the like.
The dual-excitation orthogonal emission up-conversion luminescent nanoparticle prepared by the method is characterized in that the up-conversion luminescent nanoparticle can emit any one of red light or green light wave bands under the excitation of two different near infrared lights at the same time, namely, one near infrared excitation light can excite light of one wave band.
The high-sensitivity double-flux detection immunochromatography test strip based on the double-excitation orthogonal emission up-conversion luminescent nano particles is characterized in that a sample pad is arranged in the center of a bottom plate, and two sides of the sample pad are sequentially adhered with a binding pad, an NC film and water absorbing paper. The assembly sequence is as follows: firstly, arranging two detection tracks on a nitrocellulose membrane, scribing a treated UCNPs solution onto an NC membrane along a specific track to form two test lines, symmetrically assembling the NC membrane on a bottom plate, and then sequentially adhering a bonding pad, water absorbing paper and a sample pad, wherein the sample pad is assembled at the center of a test strip; gold nanoparticles are arranged on the binding pad, and antibodies of the objects to be detected are marked on the gold nanoparticles; an antigen of a detection object marked by the dual-excitation orthogonal emission up-conversion luminescence nano particle is immobilized on the nitrocellulose membrane.
The high-sensitivity double-flux detection immunochromatographic test strip is characterized in that the up-conversion luminescent nano particles can emit any one of red light or green light under the excitation of two different near infrared lights, and only two test lines for fixing a detection object marked by the double-excitation orthogonal emission up-conversion luminescent nano particles are required to be marked on a nitrocellulose membrane of the chromatographic test strip, so that signals of one wave band of the double-excitation orthogonal emission up-conversion nano particles under the near infrared excitation light are used as detection T lines, and signals of the other wave band can be used as quality control C lines, thereby achieving the effect of multiple bidirectional single-line detection.
The high-sensitivity double-flux detection immunochromatography test strip is characterized in that a sample pad of the double-flux test strip is arranged in the center of a bottom plate, a binding pad, an NC film and absorbent paper are adhered to the two sides of the sample pad in a symmetrical sequence, the high-sensitivity double-flux detection immunochromatography test strip is different from a unidirectional detection test strip, gold particles coupled with ochratoxin A and vomitoxin antibody are respectively fixed on the binding pads at the two ends of the double-flux test strip, and UCNPs coupled with the ochratoxin A and vomitoxin antigen are fixed on corresponding T lines.
The high-sensitivity double-flux detection immunochromatography test strip for the double-excitation orthogonal emission up-conversion luminescence nano-particles is characterized in that: the commercial nitrocellulose membrane was 60cm in size; the bonding pad is made of two glass fibers with the length of 5mm, the length of the sample pad is 10mm, and the sample pad is stuck to the middle position of the nitrocellulose membrane during assembly.
The detection method of the colloidal gold immunochromatographic test strip for fluorescence quenching of the double-excitation double-emission up-conversion luminescence nano-particles is characterized by comprising the following steps of:
(1) When the prepared chromatographic test strip does not drop the sample to be detected on the binding pad, the two different detection signals are obtained by exciting the antigen of the detection object marked by the luminescent nanoparticle through the double-excitation orthogonal emission up-conversion fixed on the nitrocellulose membrane through 980nm and 808nm lasers respectively.
(2) When the sample does not contain detection substances, the sample is dripped on the binding pad, and all the gold nanoparticles flow into the nitrocellulose membrane and are combined with the antigen of the detection substances marked by the double-excitation orthogonal emission up-conversion luminescence nanoparticles fixed on the membrane. Because the absorption area (520 nm) of the gold nanoparticles is exactly coincident with the green light emission area (540 nm) of the up-conversion luminescence nanoparticles under 808nm laser excitation, the gold nanoparticles can quench the green light of the up-conversion luminescence nanoparticles; however, the red light emission area (660 nm) of the up-conversion luminescence nano-particles is not affected, so that a red light signal under 980nm laser excitation can be used as a quality control C line of a detection sample;
The step (2) further comprises the following steps:
During detection, solutions of detection objects with different concentrations are respectively dripped on the sample pad for detection. The detection sample can be combined with the antibody corresponding to the object to be detected marked on the gold nano-particles, the detection sample can form an aggregate with a part of the gold nano-particles, the aggregate is left on the combination pad, and the other part of the gold nano-particles can flow into the nitrocellulose membrane along with the rest detection sample to two sides and are combined with the antigen of the object to be detected marked by the double-excitation orthogonal emission up-conversion luminescent nano-particles fixed on the nitrocellulose membrane. Because only a part of the gold nanoparticles are combined with the antigen of the detection object marked by the dual-excitation orthogonal emission up-conversion luminescence nanoparticles fixed on the nitrocellulose membrane, the gold nanoparticles cannot completely quench the green light of the up-conversion luminescence nanoparticles, and the quenching effect gradually decreases along with the increase of the concentration of the detection object, namely the green light signal gradually increases. At this time, the green light signal under 808nm laser excitation can be used as a detection T line for detecting the sample. The fluorescence intensity of the T line and the C line of the quality inspection are obtained through 980nm and 808nm laser excitation, the ratio of the fluorescence intensity of the T line to the fluorescence intensity of the C line is established, and the quantitative detection of the two components in the sample to be inspected is realized through the comparison with a standard curve.
The beneficial effects of the invention are mainly as follows:
1. The double-flux detection immunochromatography test strip provided by the invention only comprises two detection lines, has a simple structure, is a novel immunochromatography test strip capable of rapidly detecting two mycotoxins, mainly utilizes double-excitation orthogonal emission up-conversion luminescence nano particles to have two signals, and can realize single-line detection of two detection substances after being combined with colloidal gold; test strip stability: can be stably maintained for at least 3 years.
2. The preparation method of the up-conversion luminescent nano-particles based on the dual-excitation orthogonal emission has the advantages of simple process and easy implementation; the dual-excitation dual-emission up-conversion luminescent nanoparticle has 980nm excitation red light and 808nm excitation green light; the particle size is small: d is approximately equal to 30nm; the dispersity is good: PDI <0.3.
3. According to the detection method of the double-flux detection immunochromatography test strip, UCNPs are used as a biological marker labeled antibody, the luminous results of two T lines can be directly observed under the excitation of near infrared light, and the background interference is eliminated due to the unique optical characteristics of the UCNPs, the background value is low, the signal is stable, and the sensitivity is greatly improved; and UCNPs in the test paper are harmless to testers and the environment, and have good safety.
4. According to the detection method of the double-flux detection immunochromatography test strip, more pretreatment is not needed for a sample to be detected, quantitative measurement can be directly realized by means of the up-conversion luminescence sensor, the operation is simple and quick, the on-site operation can be realized, the detection is quick within 3-10 min, and the result accuracy is high.
Drawings
FIG. 1 is a transmission electron microscope image of a dual excitation orthogonal emission up-conversion nanoparticle;
FIG. 2 is a schematic reaction diagram of an immune reaction;
FIG. 3 is a schematic diagram of the detection principle of the high-sensitivity dual-throughput detection immunochromatography test strip based on dual-excitation orthogonal emission up-conversion luminescence nano-particles.
FIG. 4 is a schematic diagram of the detection result of a high-sensitivity dual-throughput detection immunochromatography test strip based on dual-excitation orthogonal emission up-conversion luminescent nano-particles.
FIG. 5 is a schematic diagram of a high-sensitivity dual-throughput detection immunochromatographic test strip based on dual-excitation orthogonal emission up-conversion luminescent nanoparticles.
Detailed Description
Referring to fig. 1 to 5, the following detailed description of the technical solution of the present invention is given by way of examples and drawings.
Example 1:
The preparation method of the dual-excitation orthogonal emission up-conversion luminescent nanoparticle provided by the embodiment is used for preparing the dual-excitation orthogonal emission up-conversion luminescent nanoparticle with 980nm excitation red light and 808nm excitation green light, then combining with colloidal gold to prepare a dual-throughput detection immunochromatography test strip, and simultaneously detecting ochratoxin A and vomitoxin, and comprises the following steps:
1. Preparation of UCNPs
1.1 Preparing a double-excitation orthogonal emission up-conversion luminescent nanoparticle with a three-layer core-shell structure by adopting a seed crystal method, wherein NaYF 4 nanoparticle doped with Yb, tm and Er is taken as an inner core, a first shell layer of Yb doped NaYF 4 is wrapped outside the inner core, and a second shell layer of Yb and Nd doped NaYF 4 is wrapped outside the first shell layer to form a Yb, tm, er and Nd co-doped NaYF 4:Yb/Tm/Er@NaYF4:Yb@NaYF4 of a Yb/Nd core-shell structure; the water-soluble dual-excitation orthogonal emission up-conversion luminescent nano-particles UCNPs are prepared, and the up-conversion luminescent nano-particles emit red light under the excitation of 980nm near infrared light and emit green light under the excitation of 808nm near infrared light.
The step (1) specifically comprises the following steps:
a. Synthesizing NaYF 4 nano-particles doped with Yb, tm and Er as inner cores
10ML of Oleic Acid (OA), 10mL of Octadecene (ODE), 0.84g of NaF solid and 3 0.0683g、Tm(OAc)3 0.0017g、Er(OAc)3 0.2752g of Yb (OAc) are weighed and added into a three-neck flask A, the temperature is raised to 110-120 ℃ by magnetic stirring, the temperature is kept for 10min, and then the vacuum is pumped to remove water and oxygen; after the removal, introducing N 2, heating to 300 ℃, and reacting for 1h;
b. Wrapping a first shell layer of Yb doped NaYF 4 outside the inner core
4ML of Oleic Acid (OA), 4mL of Octadecene (ODE), 0.4788g of NaF solid and 3 0.07.07 g of Yb (OAc) are weighed and added into a three-neck flask B, the temperature is raised to 110-120 ℃ by magnetic stirring, the mixture is kept for 10min, and then the water and oxygen are removed by vacuumizing; introducing N 2 after the removal, heating to 150 ℃, and after the reaction in the step a is finished, injecting the mixture into the three-neck flask A at the speed of 0.13mL/min by using a needle tube, and reacting for 1h at 300 ℃;
c. a second shell layer wrapping Yb and Nd outside the first shell layer
Weighing 4mL of Oleic Acid (OA), 4mL of Octadecene (ODE) and 3 0.0525g、Nd(OAc)3 0.4333g of Yb (OAc), adding into a three-neck flask C, magnetically stirring and heating to 110-120 ℃, keeping for 10min, and vacuumizing to remove water and oxygen; introducing N 2 after the removal, and after the reaction in the step b is finished, injecting the mixture into the three-neck flask A at the speed of 0.13mL/min by using a needle tube, and reacting for 100min at 300 ℃; cooling to room temperature after the reaction is finished, and centrifuging the reaction liquid in the three-neck flask A in a centrifuge tube to separate out the obtained nano particles;
d. Stripping oleic acid from the nanoparticle surface obtained in step c
Taking the nano particles obtained in the step c, adding a mixed solution of ethanol and concentrated hydrochloric acid (7.5 mL of ethanol and 62.5 mu L of concentrated hydrochloric acid) with pH=1 into the nano particles, carrying out ultrasonic dispersion uniformly, vibrating while carrying out ultrasonic treatment for 30min, centrifuging, removing supernatant, adding a mixed solution of ethanol and concentrated hydrochloric acid (7.5 mL of ethanol and 7.5mL of concentrated hydrochloric acid) with pH=4 into the obtained nano particles, carrying out ultrasonic dispersion uniformly, vibrating while carrying out ultrasonic treatment for 30min, carrying out centrifugal separation again, and washing the obtained nano particles to obtain the water-soluble double-excitation orthogonal emission up-conversion luminescent nano particles UCNPs.
2. Preparation of UCNPs-antigen
The pH of the mixed solution is adjusted to about 8.5 by adding 0.02moL/L of K 2CO3 solution into the water-soluble dual-excitation orthogonal emission up-conversion luminescent nano particles with the concentration of 1 mg/mL. 10. Mu.g of AFB1 antigen was added to the mixed solution, and after mixing homogeneously for 30 seconds, incubation was performed in a shaker at 37℃for 23 minutes with shaking. 200. Mu.L of BSA (mass fraction: 10%) solution and 200. Mu.L of PEG 20000 (mass fraction: 1%) solution were then added to the mixed solution and incubation was continued in a shaker at 110℃for 15min with shaking. And (3) placing the mixed solution into a centrifuge tube, centrifuging for 30min at the temperature of 13000r/min and the temperature of 4 ℃, and dispersing the mixed solution into a PBS buffer solution containing 1% BSA and having the concentration of 0.01M, pH =7.0, thereby completing the preparation of the solution of the double-excitation orthogonal emission up-conversion luminescent nano particles marked with the antigen of the AFB1 to be detected.
3. Preparing a colloidal gold solution:
0.25mL of 0.1M chloroauric acid solution was added to 100mL of ultrapure water, and heated under magnetic stirring to reflux to boiling. 1.5mL of 1% sodium citrate solution was added rapidly and reflux continued for about 30 minutes. During which the color of the solution changed from pale yellow to black and then to deep red. And (3) cooling to room temperature, and filtering the prepared wine-red gold nanoparticle sol by using a filter membrane with the diameter of 0.22 mu m to obtain gold nanoparticles.
4. Preparation of AuNPs-antibodies
10ML of the prepared gold nanoparticles were collected and concentrated to 2mL by centrifugation. 0.02moL/L K 2CO3 solution was added to 1mg/mL gold nanoparticles, and the pH of the mixed solution was adjusted to about 8.5. 10. Mu.g of AFB1 antibody was added to the mixed solution, and after mixing homogeneously for 30 seconds, incubation was performed in a shaker at 110℃for 20 minutes with shaking. 200. Mu.L of BSA (10% by mass) and 200. Mu.L of PEG 20000 (1% by mass) were added to the mixture and incubation was continued with shaking in a shaker at 37℃for 15min. The mixed solution is placed in a centrifuge tube, centrifuged for 30min at 13000r/min and 4 ℃, and then dispersed in PBS buffer solution containing 1% BSA and 0.01M, pH =7.0, thus completing the preparation of the gold nanoparticle solution of the antibody of AFB1 to be detected.
5. The preparation of the chromatographic test strip has a specific structure shown in figure 5.
Two pieces of round glass fibers (conjugate pads) having a width of 5mm were immersed in an antibody-Au NP solution having a concentration of 4mg/mL for 10 minutes, and then dried at 37℃for 2 hours. Antigen (OTA-BSA, DON-BSA) conjugated UCNPs solution was diluted to 4mg/mL and streaked onto NC membrane along a specific distance at a concentration of 1.5. Mu.L/cm, respectively, to form two symmetrical T lines, which were further dried at 37℃for 2 hours. The sample pad is assembled in the center of the test strip. Finally, the assembled test strips were cut to size and stored in a refrigerator at 4 ℃ for future use.
The commercial nitrocellulose membrane was 60cm in size; the combination pad is a circular glass fiber with the width of 5mm, the diameter of the sample pad is 10mm, and the sample pad is stuck to the middle position of the test strip during assembly.
The high-sensitivity double-flux detection immunochromatography test strip based on the double-excitation orthogonal emission up-conversion luminescence nano-particles further comprises the following steps:
(1) Treatment of bond pads
Taking a glass cellulose film as a bonding pad material, firstly soaking the bonding pad in a bonding pad treatment liquid for 24 hours, drying at 37 ℃, putting the bonding pad into the solution of the double gold nanoparticles marked with the OTA and DON antibodies to be detected obtained in the step 1, soaking for 10 minutes, and drying at 37 ℃ to finish the treatment of the bonding pad; the conjugate pad treatment was a PBS buffer solution containing 1% bas, 2% tween-20 and 5% sucrose at a mass concentration of 0.01M, pH =7.4.
(2) Treatment of nitrocellulose membranes
Marking a specific annular orbit of a solution of the double-excitation orthogonal emission up-conversion luminescence nano particles marked with the antigen of OTA and DON to be detected on a nitrocellulose membrane with a parameter of 1.5 mu L/cm, and drying to finish the treatment of the nitrocellulose membrane;
(3) Assembly of test strips
And (3) adhering the treated bonding pad to the center position of each test ring on the nitrocellulose membrane, thus completing the assembly of the multiple double-throughput detection test strip.
6. Detection method and process of colloidal gold immune test strip
(1) When the prepared chromatographic test strip does not drop the sample to be detected on the sample pad, the two different detection signals are obtained by exciting the antigens of the detection object marked by the luminescent nano particles through the double-excitation orthogonal emission up-conversion fixed on the nitrocellulose membrane through 980nm and 808nm lasers respectively.
(2) When the sample does not contain detection substances, the sample is dripped on a sample pad, and all gold nanoparticles flow into nitrocellulose membranes towards two sides and are combined with antigens of the detection substances marked by the double-excitation orthogonal emission up-conversion luminescence nanoparticles fixed on the nitrocellulose membranes. Because the absorption area (520 nm) of the gold nanoparticles is exactly coincident with the green light emission area (540 nm) of the up-conversion luminescence nanoparticles under 808nm laser excitation, the gold nanoparticles can quench the green light of the up-conversion luminescence nanoparticles; however, the red light emission area (660 nm) of the up-conversion luminescence nano-particles is not affected, so that a red light signal under 980nm laser excitation can be used as a quality control C line of a detection sample;
The step (2) further comprises the following steps:
During detection, solutions of detection objects with different concentrations are respectively dripped on the sample pad for detection. The detection sample can be combined with the antibody corresponding to the object to be detected marked on the gold nano-particles, the detection sample can form an aggregate with a part of the gold nano-particles, the aggregate is left on the combination pad, and the other part of the gold nano-particles and the rest of the detection sample flow into the nitrocellulose membrane together and are combined with the antigen of the object to be detected marked by the double-excitation orthogonal emission up-conversion luminescent nano-particles fixed on the membrane. Because only a part of the gold nanoparticles are combined with the antigen of the detection object marked by the dual-excitation orthogonal emission up-conversion luminescence nanoparticles fixed on the nitrocellulose membrane, the gold nanoparticles cannot completely quench the green light of the up-conversion luminescence nanoparticles, and the quenching effect gradually decreases along with the increase of the concentration of the detection object, namely the green light signal gradually increases. At this time, the green light signal under 808nm laser excitation can be used as a detection T line for detecting the sample. The fluorescence intensity of the T line and the C line of the quality inspection are obtained through 980nm and 808nm laser excitation, the ratio of the fluorescence intensity of the T line to the fluorescence intensity of the C line are established, and the quantitative detection of two components (OTA and DON) contained in the sample to be detected is realized through the comparison with a standard curve.
The foregoing description of the exemplary embodiments of the invention is not intended to limit the invention to the precise form disclosed, and any modifications, equivalents, and alternatives falling within the spirit and principles of the invention are intended to be included within the scope of the invention.
Claims (9)
1. A high-sensitivity double-flux detection immunochromatography test strip is characterized in that the test strip is prepared by adopting double-excitation orthogonal emission up-conversion luminescent nano particles; the sample pad of the high-sensitivity double-throughput detection immunochromatography test strip is arranged in the center of a bottom plate, two sides of the sample pad are symmetrically and sequentially adhered with a binding pad, a nitrocellulose membrane and absorbent paper, and unlike a unidirectional detection test strip, gold nanoparticles coupled with ochratoxin A and vomitoxin antibodies are respectively fixed on the binding pads at two ends of the high-sensitivity double-throughput detection immunochromatography test strip, and double-excitation orthogonal emission up-conversion nanoparticles coupled with the ochratoxin A and vomitoxin antigens are fixed on corresponding T lines, so that when a sample to be detected is dripped, the solution to be detected migrates to two sides at the same speed; the dual-excitation orthogonal emission up-conversion luminescent nano particles can emit red light or green light in any one of two wave bands under the excitation of two different near infrared lights, namely, light in one wave band can be excited by one near infrared excitation light energy;
the dual-excitation orthogonal emission up-conversion luminescent nano-particles are prepared by the following steps:
(1) Preparing a double-excitation orthogonal emission up-conversion luminescent nanoparticle with a three-layer core-shell structure by adopting a seed crystal method, wherein NaYF 4 nanoparticle doped with Yb, tm and Er is taken as an inner core, a first shell layer of Yb-doped NaYF 4 is wrapped outside the inner core, and a second shell layer of Yb-doped NaYF 4 and Nd-doped NaYF 4:Yb/Tm/Er@NaYF4:Yb@NaYF4 which is co-doped with Yb, tm, er and Nd is wrapped outside the first shell layer, so that a Yb/Nd core-shell structure is formed; the water-soluble dual-excitation orthogonal emission up-conversion luminescent nano-particles UCNPs are prepared, and the up-conversion luminescent nano-particles emit red light under the excitation of 980nm near infrared light and emit green light under the excitation of 808nm near infrared light.
2. The high-sensitivity double-flux detection immunochromatographic test strip according to claim 1, which is characterized in that the up-conversion luminescent nano-particles can emit red light or green light under the excitation of near infrared light of two different wave bands at the same time, and only two antigen detection lines T lines of detection objects marked by the double-excitation orthogonal emission up-conversion luminescent nano-particles are required to be marked on a nitrocellulose film of the chromatographic test strip, so that signals of one wave band emitted by the double-excitation orthogonal emission up-conversion luminescent nano-particles under the near infrared excitation light are taken as detection T lines, and signals of the other wave band are taken as quality control C lines, thereby achieving the effect of bidirectional single-line detection.
3. The high-sensitivity double-throughput detection immunochromatographic test strip according to claim 1, wherein a sample pad of the high-sensitivity double-throughput detection immunochromatographic test strip is arranged in the center of a bottom plate, a binding pad, an NC film and absorbent paper are adhered in a bilateral symmetry sequence, and unlike a unidirectional detection test strip, gold particles coupled with ochratoxin A and vomitoxin antibodies are respectively fixed on the binding pads at the two ends of the double-throughput test strip, and UCNPs coupled with ochratoxin A and vomitoxin antigens are fixed on corresponding T lines.
4. The high-sensitivity dual-throughput detection immunochromatographic test strip according to claim 1, wherein: the size of the nitrocellulose membrane is 60 cm; the bonding pad is made of two pieces of glass fibers with the length of 5mm, the length of the sample pad is 10mm, and the sample pad is stuck to the middle position of the nitrocellulose membrane during assembly.
5. The high-sensitivity dual-throughput detection immunochromatographic strip of claim 1, wherein the preparation of the dual-excitation orthogonal emission up-conversion luminescent nanoparticle UCNPs further comprises the steps of:
(2) Preparation of UCNPs-antigen: the antigen of the detection object AFB1 is marked on the surface of the water-soluble dual-excitation orthogonal emission up-conversion luminescent nanoparticle through physical adsorption, so that the dual-excitation orthogonal emission up-conversion luminescent nanoparticle marked with the antigen of the detection object AFB1 is obtained.
6. The high-sensitivity double-throughput detection immunochromatographic test strip according to claim 1, wherein the gold nanoparticles are prepared by the following steps:
(1) Preparing a colloidal gold solution:
0.25 Adding the solution of the chloroauric acid with the concentration of 0.1M into the ultrapure water with the concentration of 100mL M, heating and refluxing to boiling under magnetic stirring, rapidly adding the solution of the sodium citrate with the concentration of 1.5mL and continuously refluxing for 30 minutes; the color of the solution changes from light yellow to black and then to dark red; and (3) cooling to room temperature, and filtering the prepared wine-red gold nanoparticle sol by using a filter membrane with the diameter of 0.22 mu m to obtain gold nanoparticles.
7. The high-sensitivity dual-throughput detection immunochromatographic test strip of claim 6, wherein the preparation of gold nanoparticle AuNPs further comprises the following steps:
(2) Preparation of AuNPs-antibodies: and labeling the antibody of the detection object AFB1 on the surface of the gold nanoparticle through physical adsorption to obtain the gold nanoparticle labeled with the antibody of the detection object AFB 1.
8. A detection method using the high-sensitivity dual-throughput detection immunochromatographic test strip according to any one of claims 1 to 7, comprising the steps of:
(A) When the prepared immunochromatographic test strip does not drop the sample to be detected in the center of the binding pad, the two different detection signals are obtained by exciting antigens of the detection object marked by the luminescent nanoparticle through the double-excitation orthogonal emission up-conversion on the nitrocellulose membrane through 980nm and 808nm lasers respectively;
(B) When the sample does not contain detection substances, the sample is dripped in the center of the sample pad, and the gold nanoparticles flow into two sides of the nitrocellulose membrane along with the sample and are combined with the antigen of the detection substances marked by the double-excitation orthogonal emission up-conversion luminescence nanoparticles fixed on the membrane; because the absorption area of the gold nanoparticles is exactly coincident with the green light emission area of the up-conversion luminescence nanoparticles under 808nm laser excitation, the gold nanoparticles can quench the green light of the up-conversion luminescence nanoparticles; however, the red light emission area of the up-conversion luminescence nano-particles is not affected, so that the red light signal excited by 980nm laser is used as a quality control C line of the detection sample.
9. The method of claim 8, wherein the step (B) further comprises the steps of:
During detection, solutions of detection objects with different concentrations are respectively dripped on a sample pad for detection, a detection sample is combined with antibodies corresponding to detection objects marked on gold nanoparticles on two sides, the detection sample forms an aggregate with a part of gold nanoparticles and is left on the combination pad, and the other part of gold nanoparticles flows into a nitrocellulose membrane together with the rest detection sample and is combined with antigens of the detection objects marked by the double-excitation orthogonal emission up-conversion luminescence nanoparticles fixed on the membrane; because only a part of the gold nanoparticles are combined with the antigen of the detection object marked by the dual-excitation orthogonal emission up-conversion luminescence nanoparticles fixed on the nitrocellulose membrane, the gold nanoparticles cannot completely quench the green light of the up-conversion luminescence nanoparticles, and the quenching effect gradually decreases along with the increase of the concentration of the detection object, namely the green light signal gradually increases; at this time, the green light signal under 808nm laser excitation is used as a detection T line for detecting the sample; the fluorescence intensity of the T line and the C line of the quality inspection are obtained through 980nm and 808nm laser excitation, the ratio of the fluorescence intensity of the T line to the fluorescence intensity of the C line is established, and the quantitative detection of the two components in the sample to be inspected is realized through the comparison with a standard curve.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210582109.5A CN115216288B (en) | 2022-05-26 | 2022-05-26 | High-sensitivity double-flux detection immunochromatography test strip based on double-excitation orthogonal emission up-conversion luminescence nano-particles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210582109.5A CN115216288B (en) | 2022-05-26 | 2022-05-26 | High-sensitivity double-flux detection immunochromatography test strip based on double-excitation orthogonal emission up-conversion luminescence nano-particles |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115216288A CN115216288A (en) | 2022-10-21 |
CN115216288B true CN115216288B (en) | 2024-04-26 |
Family
ID=83607768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210582109.5A Active CN115216288B (en) | 2022-05-26 | 2022-05-26 | High-sensitivity double-flux detection immunochromatography test strip based on double-excitation orthogonal emission up-conversion luminescence nano-particles |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115216288B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105974109A (en) * | 2016-06-14 | 2016-09-28 | 中州大学 | Fluorescence immunochromatography test paper for detecting ochratoxin A |
CN110987882A (en) * | 2019-11-15 | 2020-04-10 | 上海大学 | Fluorescence-quenched colloidal gold immunochromatographic test strip, preparation method and application thereof |
CN112358866A (en) * | 2020-11-17 | 2021-02-12 | 上海大学 | Orthogonal up-conversion luminescence nano probe, preparation method and application thereof |
CN112903649A (en) * | 2021-01-26 | 2021-06-04 | 上海大学 | Double-excitation orthogonal emission up-conversion luminescence nanoparticle, multi-flux detection immunochromatography test paper and application thereof |
CN112903648A (en) * | 2021-01-26 | 2021-06-04 | 上海大学 | Dual-wavelength emission upconversion nanoparticle, combined colloidal gold immunochromatographic test paper and application thereof |
-
2022
- 2022-05-26 CN CN202210582109.5A patent/CN115216288B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105974109A (en) * | 2016-06-14 | 2016-09-28 | 中州大学 | Fluorescence immunochromatography test paper for detecting ochratoxin A |
CN110987882A (en) * | 2019-11-15 | 2020-04-10 | 上海大学 | Fluorescence-quenched colloidal gold immunochromatographic test strip, preparation method and application thereof |
CN112358866A (en) * | 2020-11-17 | 2021-02-12 | 上海大学 | Orthogonal up-conversion luminescence nano probe, preparation method and application thereof |
CN112903649A (en) * | 2021-01-26 | 2021-06-04 | 上海大学 | Double-excitation orthogonal emission up-conversion luminescence nanoparticle, multi-flux detection immunochromatography test paper and application thereof |
CN112903648A (en) * | 2021-01-26 | 2021-06-04 | 上海大学 | Dual-wavelength emission upconversion nanoparticle, combined colloidal gold immunochromatographic test paper and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN115216288A (en) | 2022-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110987882B (en) | Fluorescence-quenched colloidal gold immunochromatographic test strip, preparation method and application thereof | |
CN111303878B (en) | Up-conversion luminescent nanoparticle preparation and chromatography test strip based on double excitation and double emission and detection method | |
CN105705938B (en) | Phosphorescent reporters | |
CN101893623B (en) | Rapid detection method employing ultrasensitive quantum dot microsphere immunity-chromatograph test paper strips | |
Goryacheva et al. | Nanosized labels for rapid immunotests | |
CN112903649B (en) | Double-excitation orthogonal emission up-conversion luminescence nanoparticle, multi-flux detection immunochromatography test paper and application thereof | |
Di Nardo et al. | A fluorescent immunochromatographic strip test using Quantum Dots for fumonisins detection | |
CN106680496B (en) | A kind of preparation of colorimetric fluorescence dual signal nanosphere and its application in immunochromatography quantitatively detects | |
Yu et al. | CdTe/CdS quantum dot-labeled fluorescent immunochromatography test strips for rapid detection of Escherichia coli O157: H7 | |
CN107748147B (en) | White luminous up-conversion nano-particles and test strip based on same and capable of simultaneously realizing detection of multi-component tumor markers | |
CN104101708A (en) | Up-conversion fluorescent/magnetic nanoparticles-based immune-chromatographic test paper and making method thereof | |
WO2017206800A1 (en) | Centrifugal chromatography immunoassay method | |
WO2017088214A1 (en) | Fluorescence-based biological detection system | |
Guo et al. | An up conversion optical system based on mesoporous silica encapsulated up-converting nanoparticles labeled lateral flow immunoassay for procalcitonin quantification in plasma | |
CN115216288B (en) | High-sensitivity double-flux detection immunochromatography test strip based on double-excitation orthogonal emission up-conversion luminescence nano-particles | |
KR20210060436A (en) | Capillary action test using photoluminescent inorganic nanoparticles | |
CN107870238B (en) | Method for quantitatively measuring troponin I (cTnI) in human serum | |
Calucho et al. | Nanoparticle-based lateral flow assays | |
JP4810639B2 (en) | Quantitative method using infrared fluorescent particles | |
CN104807993B (en) | Mycobacterium tuberculosis ESAT-6 protein detection kit, as well as preparation method and use method | |
CN112903648A (en) | Dual-wavelength emission upconversion nanoparticle, combined colloidal gold immunochromatographic test paper and application thereof | |
CN111175510A (en) | Bionic immunofluorescence test strip for detecting herbicide propanil and preparation method and application thereof | |
CN114280046B (en) | Colorimetric-photothermal dual-mode test strip for detecting microorganisms and preparation method thereof | |
CN103712963B (en) | A kind of fluorescence analysis method and device | |
CN113791211B (en) | Novel fluorescent silica nanosphere-anthrax antibody conjugate, and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |